BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 2778757)

  • 1. Antiphospholipid antibodies in the connective tissue diseases: their relation to the antiphospholipid syndrome and forme fruste disease.
    Buchanan RR; Wardlaw JR; Riglar AG; Littlejohn GO; Miller MH
    J Rheumatol; 1989 Jun; 16(6):757-61. PubMed ID: 2778757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Significance of anticardiolipin antibodies in connective tissue diseases].
    Scagliusi P; Tortorelli E; L'Abbate MC; Pipitone V
    Minerva Med; 1989 Oct; 80(10):1059-68. PubMed ID: 2682375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Anticardiolipin antibodies in autoimmune rheumatic diseases].
    Ergüven S; Calgüner M; Gülmezoğlu E; Sungur C; Ozcebe OI
    Mikrobiyol Bul; 1989 Jan; 23(1):1-11. PubMed ID: 2696861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical and analytical manifestations of primary antiphospholipid antibody syndrome].
    Camps García MT; Gutiérrez Rueda A; Guil García M; Perelló-González Moreno I; García Portales R; Belmonte López A; de Rámon Garrido E
    An Med Interna; 1993 Dec; 10(12):576-82. PubMed ID: 8049321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Anticardiolipin antibodies in diffuse connective tissue diseases with IgG, IgM and IgA isotypes].
    Hrncír Z; Chýlková V
    Vnitr Lek; 1990 Nov; 36(11):1041-9. PubMed ID: 2267732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
    Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
    J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of complement-fixing antiphospholipid antibodies in association with thrombosis.
    Munakata Y; Saito T; Matsuda K; Seino J; Shibata S; Sasaki T
    Thromb Haemost; 2000 May; 83(5):728-31. PubMed ID: 10823270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary antiphospholipid syndrome: features of patients with raised anticardiolipin antibodies and no other disorder.
    Mackworth-Young CG; Loizou S; Walport MJ
    Ann Rheum Dis; 1989 May; 48(5):362-7. PubMed ID: 2730164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Progress in laboratory tests of connective tissue diseases].
    Yamane K; Kato S; Sakauchi M
    Rinsho Byori; 1989 Dec; 37(12):1311-6. PubMed ID: 2614963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antiphospholipid antibodies syndrome: follow-up of patients with a high antiphospholipid antibodies titer].
    Urfer C; Pichler WJ; Helbling A
    Schweiz Med Wochenschr; 1996 Dec; 126(49):2136-40. PubMed ID: 8999502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison between the standard anticardiolipin antibody test and a new phospholipid test in patients with connective tissue diseases.
    Merkel PA; Chang Y; Pierangeli SS; Harris EN; Polisson RP
    J Rheumatol; 1999 Mar; 26(3):591-6. PubMed ID: 10090168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presence of antinucleosome autoantibodies in a restricted set of connective tissue diseases: antinucleosome antibodies of the IgG3 subclass are markers of renal pathogenicity in systemic lupus erythematosus.
    Amoura Z; Koutouzov S; Chabre H; Cacoub P; Amoura I; Musset L; Bach JF; Piette JC
    Arthritis Rheum; 2000 Jan; 43(1):76-84. PubMed ID: 10643702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiphospholipid antibodies: a disease marker in 25 patients with antinuclear antibody negative systemic lupus erythematosus (SLE). Comparison with a group of 91 patients with antinuclear antibody positive SLE.
    Meyer O; Piette JC; Bourgeois P; Fallas P; Bletry O; Jungers P; Kahn MF; Godeau P; Ryckewaert A
    J Rheumatol; 1987 Jun; 14(3):502-6. PubMed ID: 3114485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High prevalence of anti-mitochondrial antibodies among patients with some well-defined connective tissue diseases.
    Mouritsen S; Demant E; Permin H; Wiik A
    Clin Exp Immunol; 1986 Oct; 66(1):68-76. PubMed ID: 3802575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in protein S and C4b-binding protein levels in different groups of patients with antiphospholipid antibodies.
    Forastiero RR; Kordich L; Basilotta E; Carreras LO
    Blood Coagul Fibrinolysis; 1994 Aug; 5(4):609-16. PubMed ID: 7841319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiphospholipid antibodies among anti-U1-70 kDa autoantibody positive patients with mixed connective tissue disease.
    Komatireddy GR; Wang GS; Sharp GC; Hoffman RW
    J Rheumatol; 1997 Feb; 24(2):319-22. PubMed ID: 9034990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticardiolipin and complement activation: relation to clinical symptoms.
    Norberg R; Nived O; Sturfelt G; Unander M; Arfors L
    J Rheumatol Suppl; 1987 Jun; 14 Suppl 13():149-53. PubMed ID: 3612644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical value of determining the levels of lupus anticoagulant and anti-cardiolipin antibodies].
    Alekberova ZS; Nasonov EL; Prudnikova LZ; Aleksandrova LZ; Kurdiashova VF
    Ter Arkh; 1988; 60(7):84-7. PubMed ID: 3145584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Measurement of anticardiolipin antibodies and its significance in systemic lupus erythematosus].
    Bao CD; Chen SL; Jiang SJ
    Zhonghua Nei Ke Za Zhi; 1989 Feb; 28(2):74-7, 125. PubMed ID: 2500315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The antiphospholipid syndrome: the clot thickens.
    Gleason CB; Harris EN
    J Ky Med Assoc; 1992 Jan; 90(1):11-7. PubMed ID: 1556471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.